Iit Research Institute
- Assets
- $44.2m
- Revenue
- $29.9m
- Investments
- $0.0
- Employees
- 157
- Location
- Chicago, IL
- Founding
- 03/1941
- Data as of
- 09/2022
- EIN
- 36-2169122
Organization Overview
Iit Research Institute is located in Chicago, IL. The organization was established in 1941. According to its NTEE Classification (U20) the organization is classified as: General Science, under the broad grouping of Science & Technology and related organizations. As of 09/2023, Iit Research Institute employed 157 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Iit Research Institute is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 09/2022, Iit Research Institute generated $29.9m in total revenue. This represents relatively stable growth, over the past 3 years the organization has increased revenue by an average of 3.5% each year. All expenses for the organization totaled $25.5m during the year ending 09/2022. While expenses have increased by 0.6% per year over the past 3 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
RESEARCH AND DEVELOPMENT DIRECTED TOWARDS THE PREVENTION AND CURE OF DISEASE.
Describe the Organization's Program Activity:
Part 3 - Line 4a
WORKING WITH SCIENTISTS FROM THE U.S. NATIONAL CANCER INSTITUTE AND OTHER ORGANIZATIONS, PERFORM BASIC RESEARCH AND PRECLINICAL EFFICACY ASSESSMENTS OF NEW MOLECULAR ENTITIES BEING DEVELOPED FOR THE PREVENTION AND TREATMENT OF INFECTIOUS DISEASE, WITH PARTICULAR EMPHASIS ON PATHOGENIC AGENTS OF INTEREST TO THE BIODEFENSE COMMUNITY. WORKING WITH THE DEPARTMENT OF DEFENSE AND OTHER AGENCIES, SUPPORT THE DEVELOPMENT OF VACCINES AND THERAPEUTIC ENTITIES FOR INFECTIOUS AGENTS. WORKING WITH SCIENTISTS FROM THE U.S. NATIONAL INSTITUTES OF HEALTH AND OTHER AGENCIES, PERFORM PRECLINICAL ASSESSMENTS OF SMALL MOLECULE THERAPEUTICS AND BIOTHERAPEUTICS BEING DEVELOPED FOR THE TREATMENT OF STROKE, TISSUE FIBROSIS, NEUROLOGIC DISEASES, AND OTHER DISEASE ENTITIES.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
David Mccormick President & Director | OfficerTrustee | 40 | $422,808 |
Robert Baker Avp & Mgr Microbiology & Molecular Biology | Officer | 40 | $233,707 |
William Johnson Avp & Manager Toxicology | Officer | 40 | $230,851 |
Todd Bucciarelli Avp & Business Development Manager | Officer | 40 | $218,622 |
Kelly Garcia Attending Veterinarian | 40 | $208,494 | |
Sridhar Jaligama Deputy Division Manager/study Director | Officer | 40 | $174,716 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Mccauley Mechanical Construction Construction Services | 9/29/23 | $4,538,000 |
Charles River Dba Pathology Associates Pathology Services | 9/29/23 | $3,014,000 |
Petrovic Enterprises Construction Services | 9/29/23 | $649,000 |
Ridglan Farms Inc Lab Animal Services | 9/29/23 | $366,000 |
Starlims Corporation Clinical Reporting Services | 9/29/23 | $288,000 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $0 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $0 |
| Total Program Service Revenue | $29,810,000 |
| Investment income | $61,000 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $29,871,000 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $1,505,000 |
| Compensation of current officers, directors, key employees. | $301,000 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $6,935,000 |
| Pension plan accruals and contributions | $416,000 |
| Other employee benefits | $2,093,000 |
| Payroll taxes | $745,000 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $142,000 |
| Fees for services: Accounting | $88,000 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $11,000 |
| Fees for services: Other | $245,000 |
| Advertising and promotion | $0 |
| Office expenses | $73,000 |
| Information technology | $226,000 |
| Royalties | $0 |
| Occupancy | $1,526,000 |
| Travel | $143,000 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $48,000 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $2,534,000 |
| Insurance | $209,000 |
| All other expenses | $249,000 |
| Total functional expenses | $25,493,000 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $5,556,000 |
| Savings and temporary cash investments | $534,000 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $5,993,000 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $221,000 |
| Net Land, buildings, and equipment | $25,547,000 |
| Investments—publicly traded securities | $4,572,000 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $1,790,000 |
| Total assets | $44,213,000 |
| Accounts payable and accrued expenses | $3,610,000 |
| Grants payable | $0 |
| Deferred revenue | $8,368,000 |
| Tax-exempt bond liabilities | $3,360,000 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $1,860,000 |
| Total liabilities | $17,198,000 |
| Net assets without donor restrictions | $0 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $27,015,000 |
| Total liabilities and net assets/fund balances | $44,213,000 |